The most important finding with clinical applications is high CSF levels of Ng reported in MCI patients progressing to AD compared to cognitively stable MCI patients and control individuals, making CSF Ng a surrogate biomarker for identifying patients in early disease stages [118,119,120]. Here, NRGN is linked to Alzheimer disease.